Abstract
While iodine scanning is the mainstay of functional imaging in differentiated thyroid cancer, there is now a significant body of literature regarding positron emission tomography with 2-fluoro-2-deoxy glucose in thyroid cancer. This clinical review will examine the evidence supporting the use of 2-fluoro-2-deoxy glucose-positron emission tomography throughout the diagnosis and management of thyroid cancer, and provide suggestions for its clinical use and potential future roles.
Original language | English |
---|---|
Pages (from-to) | 116-124 |
Number of pages | 9 |
Journal | ANZ Journal of Surgery |
Volume | 81 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2011 |
Externally published | Yes |
Keywords
- Fluoro-deoxy glucose
- Positron emission tomography
- Thyroid neoplasm
- Thyroid nodule